The Artima Developer Community
Sponsored Link

Java Buzz Forum
CDC Software withdraws offer to buy Chordiant, sells 1.3 percent stake in the company

0 replies on 1 page.

Welcome Guest
  Sign In

Go back to the topic listing  Back to Topic List Click to reply to this topic  Reply to this Topic Click to search messages in this forum  Search Forum Click for a threaded view of the topic  Threaded View   
Previous Topic   Next Topic
Flat View: This topic has 0 replies on 1 page
Angsuman Chakraborty

Posts: 19816
Nickname: angsuman
Registered: Dec, 2003

Angsuman Chakraborty is the CEO and Chief Architect at Taragana
CDC Software withdraws offer to buy Chordiant, sells 1.3 percent stake in the company Posted: Jan 15, 2010 1:13 AM
Reply to this message Reply

This post originated from an RSS feed registered with Java Buzz by Angsuman Chakraborty.
Original Post: CDC Software withdraws offer to buy Chordiant, sells 1.3 percent stake in the company
Feed Title: Simple Thoughts - Java and Web Technology Blog
Feed URL: http://tech.gaeatimes.com/index.php/feed/
Feed Description: News and views as a Software Architect and Entrepreneur on Java and Web Software.
Latest Java Buzz Posts
Latest Java Buzz Posts by Angsuman Chakraborty
Latest Posts From Simple Thoughts - Java and Web Technology Blog

Advertisement
CDC Software withdraws offer to buy Chordiant SAN FRANCISCO — CDC Software Corp., a Chinese business software developer, said Thursday that it withdrew a recent offer to buy Chordiant Software Inc. and sold its 1.3 percent stake in the company. Earlier this month, CDC Software offered to buy all outstanding shares of business software company Chordiant for .... Source  : Gaea News Network.

Read: CDC Software withdraws offer to buy Chordiant, sells 1.3 percent stake in the company

Topic: The table stakes of 2010 and beyond Previous Topic   Next Topic Topic: Super Bowl ad prices fall because of economic slump, but still most valuable air time

Sponsored Links



Google
  Web Artima.com   

Copyright © 1996-2019 Artima, Inc. All Rights Reserved. - Privacy Policy - Terms of Use